• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在有无聚乙烯吡咯烷酮的情况下,硝苯地平在玻璃化转变温度(Tg)附近晶体生长速率的突然上升。

Sudden rise of crystal growth rate of nifedipine near T(g) without and with polyvinylpyrrolidone.

作者信息

Ishida Hajime, Wu Tian, Yu Lian

机构信息

School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53705, USA.

出版信息

J Pharm Sci. 2007 May;96(5):1131-8. doi: 10.1002/jps.20925.

DOI:10.1002/jps.20925
PMID:17455342
Abstract

The crystal growth of nifedipine in the beta polymorph has been measured from T(g) + 50 to T(g) - 20 K, where T(g) = 315 K is the glass transition temperature. A sudden 10-fold rise of growth rate was observed as the temperature decreased from above to below T(g) accompanied by a change of growth morphology. This is the same phenomenon reported by Oguni and coworkers [Hikima T, Adachi Y, Hanaya M, Oguni M. 1995. Phys Rev B 52:3900-3908] for other compounds of lower T(g). The phenomenon persisted in the presence of 1% polyvinylpyrrolidone (PVP). The presence of 1% or 2% PVP had little effect on the growth rate near T(g) + 50 K, but reduced the growth rate by 100-fold at T(g) + 9 K. These kinetic features are relevant to predicting the stability of amorphous drugs.

摘要

已测量了硝苯地平β晶型在从玻璃化转变温度T(g) + 50 K到T(g) - 20 K范围内的晶体生长情况,其中T(g) = 315 K为玻璃化转变温度。当温度从高于T(g)降至低于T(g)时,观察到生长速率突然升高了10倍,同时生长形态也发生了变化。这与Oguni及其同事[Hikima T, Adachi Y, Hanaya M, Oguni M. 1995. Phys Rev B 52:3900 - 3908]报道的其他玻璃化转变温度较低的化合物的现象相同。在1%聚乙烯吡咯烷酮(PVP)存在的情况下,该现象依然存在。1%或2% PVP的存在对T(g) + 50 K附近的生长速率影响不大,但在T(g) + 9 K时使生长速率降低了100倍。这些动力学特征与预测无定形药物的稳定性相关。

相似文献

1
Sudden rise of crystal growth rate of nifedipine near T(g) without and with polyvinylpyrrolidone.在有无聚乙烯吡咯烷酮的情况下,硝苯地平在玻璃化转变温度(Tg)附近晶体生长速率的突然上升。
J Pharm Sci. 2007 May;96(5):1131-8. doi: 10.1002/jps.20925.
2
Crystallization rate of amorphous nifedipine analogues unrelated to the glass transition temperature.与玻璃化转变温度无关的非晶态硝苯地平类似物的结晶速率。
Int J Pharm. 2007 May 4;336(1):191-5. doi: 10.1016/j.ijpharm.2006.11.052. Epub 2006 Nov 28.
3
Prediction of onset of crystallization in amorphous pharmaceutical systems: phenobarbital, nifedipine/PVP, and phenobarbital/PVP.无定形药物体系中晶型转变起始的预测:苯巴比妥、硝苯地平/PVP 和苯巴比妥/PVP。
J Pharm Sci. 2010 Sep;99(9):3887-900. doi: 10.1002/jps.22232.
4
Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.基于分子迁移率估算聚(乙烯基吡咯烷酮)固体分散体中无定形硝苯地平和苯巴比妥的结晶速率
J Pharm Sci. 2004 Feb;93(2):384-91. doi: 10.1002/jps.10526.
5
Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers.硝苯地平与亲水性载体共研磨混合物的固态及溶解速率表征
Drug Dev Ind Pharm. 2005 Sep;31(8):719-28. doi: 10.1080/03639040500216097.
6
Crystallization of organic glasses: effects of polymer additives on bulk and surface crystal growth in amorphous nifedipine.有机玻璃的结晶:聚合物添加剂对无定形硝苯地平体相和表面晶体生长的影响。
Pharm Res. 2011 Oct;28(10):2458-66. doi: 10.1007/s11095-011-0472-z. Epub 2011 Jun 3.
7
Preparation and transformation of true nifedipine polymorphs: investigated with differential scanning calorimetry and X-Ray diffraction pattern fitting methods.真硝苯地平多晶型物的制备与转化:差示扫描量热法和 X 射线衍射图谱拟合方法研究。
J Pharm Sci. 2011 May;100(5):1944-57. doi: 10.1002/jps.22419. Epub 2011 Jan 21.
8
Miscibility of nifedipine and hydrophilic polymers as measured by (1)H-NMR spin-lattice relaxation.通过¹H-NMR自旋晶格弛豫测量硝苯地平与亲水性聚合物的混溶性。
Chem Pharm Bull (Tokyo). 2007 Aug;55(8):1227-31. doi: 10.1248/cpb.55.1227.
9
Solubility of small-molecule crystals in polymers: D-mannitol in PVP, indomethacin in PVP/VA, and nifedipine in PVP/VA.小分子晶体在聚合物中的溶解度:聚维酮中的D-甘露醇、聚乙烯吡咯烷酮/醋酸乙烯酯共聚物中的吲哚美辛以及聚乙烯吡咯烷酮/醋酸乙烯酯共聚物中的硝苯地平。
Pharm Res. 2009 Apr;26(4):855-64. doi: 10.1007/s11095-008-9784-z. Epub 2008 Dec 4.
10
Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.低玻璃化转变温度吲哚美辛制剂的稳定性:聚合物类型及其浓度的影响
J Pharm Sci. 2008 Jun;97(6):2286-98. doi: 10.1002/jps.21174.

引用本文的文献

1
Calorimetric Monitoring of the Sub-T Crystal Growth in Molecular Glasses: The Case of Amorphous Nifedipine.分子玻璃中亚稳 T 晶体生长的量热法监测:以非晶态硝苯地平为例。
Molecules. 2025 Apr 9;30(8):1679. doi: 10.3390/molecules30081679.
2
Thermally Induced Phenomena in Amorphous Nifedipine: The Correlation Between the Structural Relaxation and Crystal Growth Kinetics.非晶态硝苯地平中的热致现象:结构弛豫与晶体生长动力学之间的相关性
Molecules. 2025 Jan 4;30(1):175. doi: 10.3390/molecules30010175.
3
Raman Mapping-Based Reverse Engineering Facilitates Development of Sustained-Release Nifedipine Tablet.
基于拉曼映射的逆向工程助力硝苯地平缓释片的研发。
Pharmaceutics. 2022 May 13;14(5):1052. doi: 10.3390/pharmaceutics14051052.
4
Factors Influencing the Crystallization-Onset Time of Metastable ASDs.影响亚稳无定形药物结晶起始时间的因素
Pharmaceutics. 2022 Jan 23;14(2):269. doi: 10.3390/pharmaceutics14020269.
5
A method to evaluate the effect of contact with excipients on the surface crystallization of amorphous drugs.一种评估与辅料接触对无定形药物表面结晶影响的方法。
AAPS PharmSciTech. 2014 Dec;15(6):1516-26. doi: 10.1208/s12249-014-0178-8. Epub 2014 Jul 19.
6
Mechanically induced amorphization of drugs: a study of the thermal behavior of cryomilled compounds.机械致药物非晶化:冷冻研磨化合物热行为研究。
AAPS PharmSciTech. 2012 Sep;13(3):772-84. doi: 10.1208/s12249-012-9801-8. Epub 2012 May 15.
7
Stability of amorphous pharmaceutical solids: crystal growth mechanisms and effect of polymer additives.无定形药物固体的稳定性:晶体生长机制和聚合物添加剂的影响。
AAPS J. 2012 Sep;14(3):380-8. doi: 10.1208/s12248-012-9345-6. Epub 2012 Mar 21.
8
Crystallization of organic glasses: effects of polymer additives on bulk and surface crystal growth in amorphous nifedipine.有机玻璃的结晶:聚合物添加剂对无定形硝苯地平体相和表面晶体生长的影响。
Pharm Res. 2011 Oct;28(10):2458-66. doi: 10.1007/s11095-011-0472-z. Epub 2011 Jun 3.
9
Fast surface crystallization of amorphous griseofulvin below T g.无定形灰黄霉素在玻璃化转变温度以下的快速表面结晶。
Pharm Res. 2010 Aug;27(8):1558-67. doi: 10.1007/s11095-010-0140-8. Epub 2010 Apr 23.
10
Understanding the behavior of amorphous pharmaceutical systems during dissolution.理解非晶态药物系统在溶解过程中的行为。
Pharm Res. 2010 Apr;27(4):608-18. doi: 10.1007/s11095-009-0021-1. Epub 2010 Feb 12.